Abstract
A meta‐analysis encompassing 78 trials has found that most long‐acting injectable (LAI) antipsychotics were more efficacious than placebo in preventing relapse in adults with nonaffective psychosis. Individual LAI antipsychotics that demonstrated the most encouraging results for both efficacy and acceptability were aripiprazole, olanzapine, and two formulations of paliperidone. Results of the meta‐analysis were published online on Feb. 18, 2021 in the American Journal of Psychiatry.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
